That same year Gen. Tlas commented that Syria, who by this time had a joint defence agreement with Khartoum, had re designated it BW programs into it's conventional arsenal. This was a highly significant shift in military protocol. See: http://www.thewednesdayreport.com/twr/syria/syria.htm. This seemed to pass by un-noticed by most Western analysts. In 2006 unconfirmed reports hinted that Syria had received a genetically modified version of smallpox from the DPRK.
SSRC photo Times of Israel
Jill Bellamy is an internationally recognized expert on biological warfare and defence. She has formerly advised NATO and for the past seventeen years has represented a number of bio-pharmaceutical and government clients working on procurement strategy between NATO MS and Washington DC. Her articles have appeared in the National Review, The Wall Street Journal, The Washington Post, The Sunday Times of London, Le Temps, Le Monde and the Jerusalem Post among other publications. She is a CBRN SME with the U.S. Department of Defence, Chemical, Biological, Radiological and Nuclear Defence Information Analysis Center and CEO of Warfare Technology Analytics, a private consultancy based in the Netherlands.Currently she serves as Associate Fellow with the Henry Jackson Society.